Der Weg von der Entwicklung bis zur Zulassung neuer Virostatika ist bis heute mit hohen Kosten und einem großen Zeitaufwand verbunden. Sollten jedoch bereits zugelassene antivirale Medikamente eine Wirkung auf andere virale Infektionen zeigen, könnte dieser Prozess stark verkürzt werden. Daher war es Ziel dieser Arbeit, den Effekt von zugelassenen Medikamenten, gegen HSV-1, mCMV, hCMV, RSV, Parainfluenzavirus-3, DENV-2, CHIKV, Poliovirus, Masernvirus und HIV-1 zu evaluieren. Getestet wurden die Polymeraseinhibitoren ACV, GCV, CDV, sowie das neuere Medikament T-705 und die reversen Transkriptase-Inhibitoren TDF, 3TC, AZT und ABC. Außerdem die Proteaseinhibitoren SMV, GRV, DCV, LDV, ELB, VEL, SOF und DSV. TDF senkte in einer Konzentration von 10 µM die Infektiosität von HSV-1 und mCMV bis zu 1 Größenordnung. Auch ABC senkte die Infektiosität von HSV-1 und mCMV in einer Konzentration von 30 µM um 0,4 bzw. 0,6 Größenordnungen. AZT und ELB senkten die Infektiosität bei Infektionen mit HSV-1 in einer Konzentration von 30 µM um 0,4 Größenordnungen. VEL senkte die Infektiosität von mCMV bis zu einer Konzentration von 2 µM um 0,7 Größenordnungen. Durch die Substanzen ELB und LDV konnte die Replikation von DENV-2 bei einer Konzentration von 10 µM um 0,6 bzw. 0,8 Größenordnungen gesenkt werden. Die Substanzen zeigten jedoch keinen Effekt auf Infektionen mit CHIKV und Poliovirus, sodass für beide Substanzen ein virusspezifischer Effekt anzunehmen ist. Es wurde keine Wirkung der Substanzen gegen Infektionen mit Masernvirus, RSV oder Parainfluenzavirus-3 in den Versuchen beobachtet. Es wurde gezeigt, dass die verwendeten Methoden eine schnelle und effektive Möglichkeit darstellen, neue direkt-antivirale Medikamente zu etablieren. Zudem stellen die gefundenen Wirkstoffe eine gute Grundlage als Leitsubstanzen zur Entwicklung neuer Wirkstoffe dar. Weitere Versuche mit Kombinationen der wirksamen Substanzen sollten zur weiteren Therapiefindung durchgeführt werden. Damit hat die vorgelegte Arbeit eine hohe Relevanz für die weitere Forschung. / To this day, the process from development to approval of new antivirals is associated with high costs and a great deal of time. This process could be greatly shortened, if an effect of approved antiviral drugs on other viral infections could be shown. Therefore, the aim of this study was to evaluate the effect of approved drugs against infections with HSV-1, mCMV, hCMV, RSV, parainfluenza virus-3, DENV-2, CHIKV, poliovirus, measles virus and HIV-1. The polymerase inhibitors ACV, GCV, CDV, as well as the newer drug T-705 and the reverse transcriptase inhibitors TDF, 3TC, AZT and ABC were tested. In addition, the protease inhibitors SMV, GRV, DCV, LDV, ELB, VEL, SOF and DSV were included. TDF reduced the infectivity of HSV-1 and mCMV by up to 1 order of magnitude at a concentration of 10 μM. ABC also reduced the infectivity of HSV-1 and mCMV by 0.4 and 0.6 orders of magnitude, respectively, at a concentration of 30 μM. AZT and ELB reduced infectivity by 0.4 orders of magnitude in HSV-1 infections at a concentration of 30 μM. VEL reduced the infectivity of mCMV by 0.7 orders of magnitude up to a concentration of 2 μM. The substances ELB and LDV reduced the replication of DENV-2 by 0.6 and 0.8 orders of magnitude, respectively, at a concentration of 10 μM. However, the substances had no effect on CHIKV and poliovirus infections, and it was assumed that both substances had a virus-specific effect. No effect of the substances against infections with measles virus, RSV or parainfluenza virus-3 was observed in the trials. The methods used proved to be a fast and effective way to establish new direct antiviral drugs. In addition, the used drugs provide a good basis as lead substances for the development of new antiviral drugs. Further experiments with combinations of the active substances should be carried out in order to find further antiviral therapies. Thus, the submitted work has a high relevance for further research.

Research was conducted at the Mississippi State University Delta Research and Extension Center from 2016 to 2018 to determine the effects of sub-lethal concentrations of paraquat, glyphosate, saflufenacil, and sodium chlorate exposure to rice at late-season growth stages, determine the effects of exposure to sub-lethal concentrations of glyphosate or paraquat on multiple rice cultivars, and characterize the effects of paraquat exposure and Oebalus pugnax feeding on rice grain quality. In the current research, rough rice grain yields were reduced by exposure to sub-lethal concentrations of soybean desiccants 0 to 28 DAH. Rice injury was determined to not be an accurate predictor of rough rice grain yield loss as injury did not exceed 20% with any desiccant, and no injury was observed from glyphosate applications. Rough rice grain yield reductions were reflected in yield component reductions following desiccant exposure. Applications of sub-lethal concentrations of glyphosate or paraquat to rice at 50% heading caused rough rice grain yield decreases ranging from 0 to 20 and 9 to 21 % respectively. Hybrid cultivars were unaffected following glyphosate exposure at 50% heading. In the current research, observations of paraquat exposure or O. pugnax infestation of rice at the soft dough growth stage suggest rice may exhibit severe sensitivity to both events in the form of reduced kernel weight and reductions in rice milling quality. Rough rice grain yield reductions coupled with milling quality reductions and driven by the proximity of rice to corn, cotton, soybean, and sorghum in Mississippi creates the need to exercise caution when applying desiccants.

Small satellites refer to a new breed of smaller and computationally capable satellites, which serve as a ?faster, better, cheaper? means of realizing space missions. To ensure success of a small satellite mission, it is important that systems engineering be applied at the initial stages of the program formalization to provide a basis for defining mission strategies, managing requirements, risk analysis, performing design trades and estimating cost. The objective of this thesis is to formalize a small satellite mission plan while providing recommendations in areas involving design optimization, systems engineering, project management, cost modeling, subsystem design and selection. Finally, this thesis details the preliminary design of a conceptual ?MSUSAT? small satellite, using Commercial Off The Shelf (COTS) components, from a systems engineering perspective. It explains the choice of orbit, payload and other subsystem components that are necessary to ensure that the mission fulfils its objective.

No description available.

No description available.

No description available.

No description available.

No description available.

No description available.

No description available.